Introduction
============

Women are twice as likely to develop post-traumatic stress disorder (PTSD) following a traumatic experience when compared with men.^[@bib1]^ Studies suggest that this increased risk among women is not due to higher rates of trauma or to differences in the types of trauma commonly experienced by women.^[@bib2],\ [@bib3],\ [@bib4]^ Further, the higher rates of PTSD among women cannot be attributed to comorbid psychiatric disorders.^[@bib3]^ However, women are more likely to report depression and anxiety symptoms at different phases of their menstrual cycle, particularly during periods characterized by low estrogen levels.^[@bib5],\ [@bib6],\ [@bib7],\ [@bib8],\ [@bib9],\ [@bib10]^

The physiological effects of estrogen are widespread. Variations in estrogen levels have been linked to differences in the hypothalamic-pituitary-adrenal axis response to stress and variation in multiple neurotransmitter systems.^[@bib11],\ [@bib12],\ [@bib13]^ Women who had recently experienced trauma reported more trauma-related flashbacks if they were in the mid-luteal phase of their cycle at the time of either the trauma or the assessment.^[@bib14]^ Further, women with PTSD report more severe psychological symptoms based on the phase of their menstrual cycle.^[@bib15]^ Consistent with this observation, female rodents also show more fear and anxiety-related behaviors in phases of their estrous cycle characterized by low estrogen levels, specifically the metestrous or diestrous phases. ^[@bib16],\ [@bib17],\ [@bib18],\ [@bib19]^

Emerging evidence suggests that estrogen may have an impact on the degree to which memories, especially fear-related memories, are formed or retrieved. For example, neuroimaging studies show greater activation of neural networks involved in fear expression when women are assessed during low estrogen periods of their cycle (follicular phase) relative to high estrogen phases,^[@bib20],\ [@bib21]^ and this is supported by focused studies of fear learning. A study by Glover and colleagues demonstrated that, compared with men, women in the high estrogen phase of their cycles (luteal phase) had no difference in their ability to discriminate between danger or safety cues nor to inhibit fear in response to a safety cue. However, women in the low estrogen phase of their cycles (follicular phase) had significantly impaired fear inhibition.^[@bib22]^ Studies in both humans and animals support this observation by demonstrating that low estrogen levels associate with deficits in fear extinction recall when compared with phases characterized by higher estrogen.^[@bib23],\ [@bib24],\ [@bib25]^ Women with PTSD have particular deficits in fear extinction when estrogen levels are low, suggesting that low estrogen at the time of trauma may be a vulnerability factor for PTSD development.^[@bib26],\ [@bib27]^

Estrogen can also moderate risk alleles implicated in PTSD,^[@bib28]^ suggesting that the effects of estrogen can vary between individuals. For example, we previously reported that a genetic variant in the PAC1 receptor associates with PTSD in a primarily African American cohort of women but not men.^[@bib28]^ The risk allele appears to alter functioning of a putative estrogen response element, potentially through epigenetic mechanisms, including DNA methylation or chromatin modifications. DNA methylation, an epigenetic modification previously associated with PTSD diagnosis,^[@bib29],\ [@bib30],\ [@bib31],\ [@bib32]^ is one mechanism that may provide insight into sex differences in stress-related disorders.^[@bib33],\ [@bib34]^ Such sex differences, many of which occur near estrogen receptor regulatory elements, are established during development, although their function may not become apparent until later in life.^[@bib34],\ [@bib35]^

In this study, we evaluated the hypothesis that individual variation in response to estrogen levels contributes to fear regulation and PTSD risk in women through differential epigenetic processes. Using nonbiased approaches, we identified an association between methylation of CpG sites in histone deacetylase 4 (*HDAC4*) in women with PTSD. HDAC4 is a class IIa HDAC that has been previously implicated in learning and memory; however, its regulation in amygdala-mediated forms of learning has not yet been established.^[@bib36],\ [@bib37],\ [@bib38],\ [@bib39]^ Using a well-characterized mouse model of fear learning, we examine the regulation of *HDAC4* in the amygdala at the time of fear memory formation and its potential interaction with estrogenic tone. Although it is inappropriate to suggest that rodents develop PTSD, the conservation of neuronal circuitry known to mediate responses to traumatic events from mouse to human and the simplicity of rodent models of fear learning have contributed to the utility of these models. As we also know that the onset of PTSD is intricately tied to a traumatic event or series of associated traumatic events, using rodent models to investigate the neurobiological and molecular mechanisms necessary for traumatic memory formation as a result of exposure to tone-shock presentations are vital towards advancing our understanding of PTSD.

Materials and methods
=====================

Participants and assessments
----------------------------

This study evaluated women recruited as part of the Grady Trauma Project (GTP), a larger study investigating the influence of genetic and environmental factors on the development of PTSD in a predominantly African American, urban population of low socioeconomic status.^[@bib22],\ [@bib28],\ [@bib40],\ [@bib41],\ [@bib42]^ In brief, research participants were approached in the waiting rooms of the primary care clinic or obstetrical-gynecological clinic of a large, urban, public hospital in Atlanta, GA, while either waiting for their medical appointments or while waiting with others who were scheduled for medical appointments. Subjects willing to participate provided written informed consent and participated in a verbal interview and blood draw. Current PTSD diagnosis was assessed using the modified PTSD Symptom Scale, a 17-item self-report scale with excellent internal consistency, high test--retest reliability, and concurrent validity to diagnose PTSD consistent with Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria.^[@bib43],\ [@bib44]^ Estradiol assays were conducted in serum by the Yerkes Biomarkers Core Laboratory at Emory University as described in the [Supplementary Information](#sup1){ref-type="supplementary-material"}. A subset of subjects underwent a fear conditioning paradigm that has been previously described and neuroimaging to assess functional connectivity.^[@bib41],\ [@bib42]^ Both protocols are described in detail in the [Supplementary Information](#sup1){ref-type="supplementary-material"}. Study procedures were approved by the Institutional Review Board of Emory University School of Medicine and the Grady Health Systems Research Oversight Committee.

Genetic and epigenetic assays
-----------------------------

Detailed genetic methods can be found in the [Supplementary Information](#sup1){ref-type="supplementary-material"}. Whole blood was collected in EDTA tubes (for DNA extraction) or Tempus tubes (for RNA extraction). DNA methylation was assessed using the HumanMethylation450 BeadChip (Illumina, San Diego, CA, USA) as previously described.^[@bib30]^ Beta Mixture Quantile dilation was used to normalize the data set.^[@bib45]^ RNA expression was assessed as part of a previous genome-wide study in this cohort.^[@bib46]^ The array was log~2~-transformed and normalized using the Supervised Normalization Method.^[@bib46]^ In total, 15 877 probes, including the one interrogating *HDAC4* (ILMN_1764396), were sufficiently expressed in blood (that is, had sufficient detection *P*-values).

Methylation probes (87 388) corresponding to the 15 877 transcripts expressed in blood were included in this analysis. Probe locations relative to a gene were determined from the annotation file for the array. For each CpG site, methylation proportion was modeled as a linear function of estradiol (*N*=239) or PTSD (*N*=278), adjusting for age, cellular proportions, positional effects and ancestry (three principal components from genome-wide association studies). For analyses of estradiol and PTSD, a Bonferroni correction was used to adjust for 87 388 tests.

Genotyping was performed using the Omni-Quad 1 M or the Omni Express BeadChips (Illumina) as previously described.^[@bib47],\ [@bib48]^ Genotypes for rs7570903 did not deviate from Hardy--Weinberg proportions, and 118 women had available genotype and methylation data. To test for association, cg22937172, each outcome was regressed on rs7570903 allele count assuming an additive model (0, 1 or 2 copies of risk allele), including sex and ancestry from top genome-wide association study principal components. Similar models were used to test for association between rs7570903 and *HDAC4* expression (ILMN_1764396; *N*=82), startle response (*N*=95), and functional connectivity (*N*=38) in women from the broader GTP cohort with available data. For each of these hypothesis-driven tests, *P*\<0.05 was considered significant.

As detailed in the [Supplementary Information](#sup1){ref-type="supplementary-material"}, Epstein--Barr transformed lymphoblastoid cell lines were selected from the 1000Genomes Project according to the *HDAC4* rs7570903 genotype (CC or TT). ^[@bib49]^ A *t*-test was used to compare *HDAC4* messenger RNA (mRNA) expression, which was considered to be statistically significant if *P*\<0.05.

Animals and ovariectomy surgical procedures
-------------------------------------------

Adult female C57bl/6J mice, aged 8--10 weeks were obtained from Jackson Labs (Bar Harbor, ME, USA). Female mice were administered i.p. ketamine (75 mg kg^−1^)/dexdomitor (1 mg kg^−1^) anesthesia to induce sedation. Upon sedation, mice were ovariectomized (OVX) and implanted with silastic capsules, composed of 2 mm silastic tubing (0.078-by-0.125 inch) containing sesame oil (OVX+Veh) or 1 μg μl^−1^ Estradiol (OVX+E), a dose based on Jasnow *et al.*^[@bib50]^ As female mice housed together have been observed to have irregular estrous cycling mice used in the naturally cycling experiment were presented with bedding from male mouse cages either 5 days (metestrous) or 3 days (proestrous) before fear conditioning to encourage estrous cycling.^[@bib51]^ All procedures involving animals were approved by the Emory University institutional animal care and use committee and conducted under the standards upheld by the National Institutes of Health.

Tone-shock conditioning procedures
----------------------------------

OVX female mice were habituated to the training context for 10 min on 2 consecutive days. On the third day, mice were returned to the training context and exposed to five trials of tone-shock pairings consisting of a 30 s, 75 db, 6 khz tone-conditioned stimulus that co-terminated with a 500 ms, 0.6 mA shock-unconditioned stimulus administered through the grid floor. A lower intensity tone-shock conditioning protocol was used for the mice undergoing ovariectomy compared with the naturally cycling group, as we have found that animals undergoing surgical procedures have some level of stress exposure and are thus more sensitive to future tone-shock experiences in the future. Animals were removed from the training context and placed in their cages for 2 h before being rapidly sedated for decapitation and brain collection.

*Hdac4* expression
------------------

Bilateral punches of the basal lateral nucleus of the amygdala (BLA) were taken using a sliding-freezing microtome and stored at −80. Extracted RNA from the punches was reverse-transcribed to complementary DNA for quantitative PCR analysis to determine *Hdac4* expression. (Note that lower case refers to the murine gene, whereas upper case refers to the human gene). Quantitative PCR analysis to examine *Hdac4* expression accompanying fear conditioning in the amygdala was conducted using the 2^ΔΔ^ Ct method and normalized to GAPDH Cts as detailed in the [Supplementary Information](#sup1){ref-type="supplementary-material"}. Group differences were ascertained using these normalized values and conducting *t*-tests. Analyses were only considered to be statistically significant if *P*\<0.05.

Results
=======

Estradiol levels associate with DNA methylation
-----------------------------------------------

We evaluated 239 women that represent the range of serum estradiol in adult women during childbearing years, pregnancy and menopause (2.85--546 pg ml^−1^). A genome-wide analysis revealed that 18 254 CpG sites associated with estradiol levels (*P*\<0.05), 390 of which remained associated after a Bonferroni correction for multiple testing ([Figure 1](#fig1){ref-type="fig"}), suggesting that methylation of genes across genome are influenced by estradiol-mediated signaling. Evaluation of women that fell within the normal cycling range for adults (30--400 pg ml^−1^; *N*=84) were consistent with the results of the overall analysis (*r*=0.32; *P*\<0.00001).

DNA methylation differences in women with PTSD
----------------------------------------------

We next examined the association between DNA methylation and PTSD in 278 women from the GTP cohort (39.2% with PTSD). Methylation of 5288 CpG sites nominally associated with PTSD (*P*\<0.05), and there was significant overlap between CpG sites that associate with PTSD and those that associate with estradiol levels (*P*\<0.0001), supporting the link between PTSD and estradiol-mediated signaling. After a Bonferroni correction for multiple tests, only cg22937172 remained associated with PTSD ([Figure 2](#fig2){ref-type="fig"}). Methylation of this CpG site in *HDAC4* was higher in PTSD cases than controls (*t*~(277)~=5.43; *P*=1.27 × 10^−7^), and higher methylation of this site was associated with lower estradiol levels (*t*~(248)~=−2.21; *P*=0.028).

Further evaluation of the region surrounding cg22937172 revealed that it is near binding sites for the glucocorticoid and estrogen receptors ([Figure 2](#fig2){ref-type="fig"}). It also revealed that the probe interrogating this CpG site contained a common single-nucleotide polymorphism (rs7570903; minor allele frequency of 33%), suggesting that methylation of cg22937172 may be influenced by an individual's genotype. Indeed, the CC genotype of rs7570903 associated with higher cg22937172 methylation (*t*~(117)~=3.47; *P*=0.0017) and lower *HDAC4* expression (*t*~(81)~= *P*=0.049). However, rs7570903 genotype did not associate with PTSD (*P*=0.067), suggesting this relationship cannot be attributed to genotype alone. To further examine genotype-dependent alterations in *HDAC4* expression, we examined baseline expression of *HDAC4* in lymphoblastoid cell lines from the Thousand Genomes Project and confirmed that cultures from CC cell lines had lower *HDAC4* mRNA levels than TT cell lines at baseline ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) in the absence of cortisol or estrogen.

*HDAC4* genotype associates with fear-related traits
----------------------------------------------------

Overexpression of conditioned fear, termed 'fear load' is considered an intermediate phenotype of PTSD and related syndromes.^[@bib52]^ As *HDAC4* is implicated in the regulation of learning and memory,^[@bib36],\ [@bib37],\ [@bib38],\ [@bib39]^ we examined whether rs7570903 genotype predicted a subject's differences in the expression of conditioned fear. GTP subjects with the CC genotype at rs7570903 exhibited enhanced fear expression on a fear-potentiated startle task (*P*=0.026; [Figure 3a](#fig3){ref-type="fig"}). PTSD also interacted with rs7570903 genotype to predict increased fear conditioning and higher fear-potentiated startle during early extinction (*P*=0.019; [Figure 3b](#fig3){ref-type="fig"}), suggesting that those with the CC genotype and PTSD have the greatest fear load.

We next examined functional brain connectivity in a highly traumatized cohort of subjects as an additional potential intermediate phenotype related to PTSD symptoms. Consistent with the idea that subjects with the rs7570903 CC genotype have higher fear load, which has been associated with structural connectivity in the cingulum tract,^[@bib53]^ we observed that the CC genotype associated with increased resting-state functional connectivity between the amygdala and cingulate cortex, two regions of the brain implicated in fear memory ([Figures 4a--c](#fig4){ref-type="fig"}).^[@bib54],\ [@bib55],\ [@bib56],\ [@bib57],\ [@bib58],\ [@bib59]^ In this analysis, we compared those with CC genotype at rs7570903 to those with one ore more copies of the T allele, examining amygdala functional connectivity data at rest. Following whole-brain correction, subjects with the CC genotype showed increased functional coupling between amygdala and dorsal cingulate cortex, compared with those with one or more copies of the T allele, independent of PTSD diagnosis (*P*\<0.05 after multiple test correction).

Tone-shock presentations in female mice regulates *Hdac4* mRNA in the amygdala
------------------------------------------------------------------------------

Before examining whether *Hdac4* is regulated in the murine brain at the time of fear memory formation, we first confirmed the expression of *Hdac4* in the amygdala, an area that is consistently implicated in the formation of fear memories and coordinating responses to threating and traumatic situations ([Figure 5a](#fig5){ref-type="fig"}).

As our clinical data suggest that regulation of *HDAC4* is altered in females with PTSD, we next sought to examine whhether *Hdac4* expression in the BLA is regulated in female mice at the time of tone-shock presentations and whether estrogen moderates any observed regulation. To this end, we conducted two experiments first, in OVX mice in the presence or absence of estrogen replacement and second, in naturally cycling females that experienced tone-shock presentations. In our first experiment, female mice were OVX and maintained with estradiol replacement or vehicle (oil) throughout recovery and behavioral testing. Following recovery, mice underwent tone-shock presentations and were then killed 2 h later ([Figure 5b](#fig5){ref-type="fig"}). Examination of *Hdac4* mRNA expression using quantitative PCR revealed an increase in *Hdac4* mRNA in tone-shock exposed mice maintained on vehicle (FC-Ovx) compared with homecage (HC-Ovx; *t*~(13)~=2.99, *P*=0.015). No difference was observed in the expression of *Hdac4* in homecage mice maintained on vehicle (HC-Ovx) or estradiol (HC-Est) (*t*~(12)~=1.07, *P*=0.31), and no difference was found in *Hdac4* expression for homecage (HC-Est) or tone-shock exposed (FC-Est) mice maintained on estradiol (*t*~(12)~=0.5, *P*=0.60). These data suggest that, although tone-shock exposure results in an increase in *Hdac4* mRNA in the BLA, this regulation may be buffered by estrogen. To further examine the potential influence of estrogen on *Hdac4* expression, we examined its regulation accompanying tone-shock exposure in naturally cycling females. Female mice underwent tone-shock exposure and were killed 2 h later, examined for estrous cycle phase and separated into metestrous (low estrogen status) and proestrous (high estrogen status) groups ([Figure 5c](#fig5){ref-type="fig"}). Examination of *Hdac4* mRNA expression in the BLA 2 h after tone-shock exposure revealed no difference in *Hdac4* between metestrous and proestrous homecage control groups (*t*~(21)~=0.539, *P*=0.59). Tone-shock exposure was found to increase *Hdac4* expression relative to homecage for metestrous (*t*~(16)~=4.99, *P*=0.0001), whereas no difference was observed in *Hdac4* expression for the proestrous tone-shock exposed relative to homecage group (*t*~(22)~=1.84, *P*=0.079). In addition, tone-shock exposure-related expression of *Hdac4* between metestrous and proestrous groups was found to be significantly different (*t*~(17)~=1.74, *P*=0.040; [Figure 5c](#fig5){ref-type="fig"}; [Supplementary Information](#sup1){ref-type="supplementary-material"}).

These data suggest that during metestrous when estrogen levels are low, a tone-shock-related regulation of *Hdac4* expression is evident, while mice in proestrous do not exhibit this regulation. These data also demonstrate the same pattern of results concerning a potential buffering of *Hdac4* expression by estrogen level in both OVX or naturally cycling females. Previous studies have noted that estrogen may be protective against the development of PTSD and may facilitate extinction recall. ^[@bib24],\ [@bib60]^ If *Hdac4* regulation in females is required for the formation of aversive memories resulting from tone-shock exposure, then our observation that mice in proestrous fail to exhibit this regulation supports the existence of estrogenic protection against traumatic memory formation accompanying experience with tone-shock exposure.

Discussion
==========

The results of this study suggest that estrogen status may increase risk for PTSD in some women, in part through its regulation of *HDAC4*. To the best of our knowledge, this is the first report of which we are aware to take an unbiased approach towards revealing alterations in DNA methylation that are associated with PTSD diagnosis in women. As summarized in [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}, DNA methylation differences in *HDAC4* associate with PTSD in women, and methylation levels of the PTSD-associated CpG site also associates with rs7570903 in a genotype-dependent manner. The CC genotype at rs7570903, which tags higher methylation levels at the PTSD-associated CpG site, associates with lower *HDAC4* expression relative to the TT genotype. Interestingly, the CpG site and single-nucleotide polymorphism lie upstream of estrogen (ESR1) and a glucocorticoid receptor (NR3C1)-binding sites ([Figure 2](#fig2){ref-type="fig"}), both of which are consistent with our hypothesis of altered *HDAC4* regulation in females with PTSD. Further examination also revealed that females with the CC genotype have heightened fear expression, or fear load, and alterations in resting-state amygdala--dorsal anterior cingulate functional connectivity. A limitation of this approach is that the human study relied primarily on biological measures from peripheral tissue, and these results could be influenced by cellular heterogeneity within whole blood or may not be reflective of processes occurring in the brain. Using mouse models to delve deeper into examining the potential influence of estrogen on *HDAC4* regulation at the time of traumatic memory formation revealed a tone-shock exposure-related increase in *Hdac4* mRNA in the amygdala in female mice with low estrogen status, either OVX or in metestrous, whereas mice with high estrogen status, OVX with estradiol replacement or in proestrous, were not observed to have tone-shock-related regulation of *Hdac4*.

PTSD is characterized by an inability to regulate emotional responses that are associated with trauma and has been associated with increased amygdala activity and alterations in precortical regions known to mediate and modulate fear memories. As PTSD emerges following a traumatic and emotionally charged event or series of traumatic events, examination of the neurobiological mechanisms that mediate fear behaviors and memory formation have proven to be productive and have substantial face validity. Indeed, just as PTSD is associated with impaired fear extinction and prolonged fear expression mediated by alterations in precortical regions and amygdala hyperactivity, human and animal studies note the importance of precortical regions in mediating and modulating fear memories by serving to inhibit amygdala responsivity to emotional stimuli.^[@bib61],\ [@bib62],\ [@bib63]^ Specifically, PTSD has been associated with decreased activation in the ventromedial prefrontal cortex, a region thought to be analogous to the rodent infralimbic cortex, which is typically noted for its importance in fear inhibition processes. In addition, PTSD is associated with increased dorsal anterior cingulate cortex (dACC) activation, a region typically noted for its role in the initial acquisition of fear behaviors and possibly analogous to the rodent prelimbic cortex, which our group has revealed to be critical for the initial formation and consolidation of fear memories,^[@bib64]^ consistent with a mechanism for the sustained fear expression.^[@bib65],\ [@bib66]^ Whereas our group has recently reported that females with PTSD have disrupted amygdala--ventromedial prefrontal cortex connectivity,^[@bib67]^ our current data reveal that subjects with the CC genotype at rs7570903 have enhanced amygdala--ACC functional connectivity. Consistent with this alteration in amygdala--dACC connectivity in PTSD, subjects with the CC genotype at rs7570903 were also found to have sustained fear expression shortly following acquisition, which may be attributable to the observed altered amygdala--dACC connectivity. As the amygdala--dACC are both brain structures that have been well implicated in fear processing in both rodent and human studies, the observation that subjects with the CC genotype have increasing resting-state connectivity between these regions may coincide with the observed prolonged fear expression in those with the CC genotype and PTSD. Future experiments will be necessary for addressing the downstream consequences of these observed differences in functional resting-state connectivity within these fear-related structures, especially in how they may be mechanistically related to alterations in fear load and expression.

The observation of higher *HDAC4* methylation in PTSD cases suggests that the role of *HDAC4* in the development of PTSD warranted further examination. Using auditory fear conditioning, a well-characterized murine model of fear memory formation, we found that OVX female mice without estradiol replacement (FC-Ovx) have a tone-shock exposure-related increase in *Hdac4* mRNA in the amygdala, whereas no regulation was observed in mice that were maintained on estradiol replacement (FC-Est). Although we did not observe a significant difference between FC-Ovx and FC-Est, the observation of differential tone-shock exposure-related regulation between FC-Ovx and FC-Est suggests a potential estrogenic buffering of *Hdac4* in response to tone-shock exposure across mammalian species.

As a class IIA HDAC, HDAC4 is trafficked from the nucleus to cytoplasm in an activity-dependent manner through Ca2+-mediated signaling,^[@bib38],\ [@bib68],\ [@bib69],\ [@bib70]^ and estrogen has been demonstrated to dampen the nuclear export,^[@bib71]^ suggesting that naturally cycling estrogenic tone may be critical in the regulation of *HDAC4*. Thus, we next examined the tone-shock exposure-related regulation of *Hdac4* in naturally cycling female mice. Similar to our OVX experiment, we observed a tone-shock exposure-related increase in *Hdac4* mRNA in mice in a low estrogen phase of estrous (metestrous), which was significantly different from tone-shock exposed mice in a high estrogen phase (proestrous). No tone-shock exposure-related regulation of *Hdac4* was observed in proestrous mice compared with homecage. These data reveal for the first time that estrogenic tone at the time of tone-shock exposure influences the regulation of *Hdac4* in the amygdala. It is worth noting that, although some studies have noted that estrogen may be protective against the acquisition of fear learning,^[@bib72]^ others have noted that estrogen appears to facilitate memory formation both across a variety of preparations including initial acquisition and the acquisition of extinction memories and further studies have demonstrated that estrogen may serve to reduce pain responses.^[@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib23],\ [@bib24],\ [@bib25],\ [@bib60],\ [@bib73]^ The implication that estrogen may alter pain perception is an important one, as our current data do not allow for direct examination of this effect. It is entirely possible that one important route through which fear behaviors may be impacted by estrogen is via alterations in pain perception, thus alterations in shock reactivity would be predicted to have a marked impact on subsequent fear expression.^[@bib60]^ An additional caveat is the previous work that has demonstrated that high levels of estrogen can impair the acquisition of fear inhibition,^[@bib74]^ which may suggest that both low and high estrogen may result in impaired memory formation and furthers contributes to the overall need for increased research in this area. Thus, given the wide range of potential roles and influences of estrogen, future studies will be necessary to reveal the functional consequences of this novel estrogenic mediation of *HDAC4* expression at the time of tone-shock exposure.^[@bib22],\ [@bib23],\ [@bib24],\ [@bib25],\ [@bib73]^

Taken together, these data suggest that regulation of *HDAC4* may increase risk for PTSD in women. Genetic and epigenetic variation can cause differences in *HDAC4* expression, although estrogen seems to provide an additional level of regulation, supported by our findings in animal models of estrogen- and stress-dependent regulation of *Hdac4* within amygdala. In traumatized human subjects, lower *HDAC4* expression, predicted by higher methylation at cg22937172 and the CC genotype at rs7570903, associates with increased resting-state functional connectivity between areas of the brain implicated in fear expression as well as heightened fear load, particularly for those with PTSD ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Future studies should further characterize the role of *HDAC4* in mediating sexually dimorphic neuroendocrine function and PTSD risk.
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![Manhattan plot of the association between estradiol levels and DNA methylation. The *x* axis is the position of each CpG site by chromosome. The *y* axis is the negative log~10~ of the *P*-value for association of each CpG site. The dashed black line indicates experiment-wide significance based on a Bonferroni correction.](mp2016250f1){#fig1}

![DNA methylation in *HDAC4* associates with post-traumatic stress disorder (PTSD) diagnosis. CpG sites are ordered by position on the *x* axis (gray lines), and the *y* axis indicates the negative log of the *P*-value for association of each CpG site with PTSD. The position of the estrogen response element and glucocorticoid response elements relative to cg22937172 are indicated. The direction of transcription is indicated by the arrow.](mp2016250f2){#fig2}

![Genetic variation in *HDAC4* associates with fear expression. (**a**) Schematic of the human physiology experiment. (**b**) Average fear-potentiated startle (FPS) difference score across the fear extinction phase for CC and CT/TT genotypes. (**c**) Average FPS difference score across the conditioning and expression (extinction) session for genotype X post-traumatic stress disorder (PTSD).](mp2016250f3){#fig3}

![*HDAC4* genotype (rs7570903) effects on amygdala functional connectivity at rest. The CC genotype groups show significant increased functional coupling of the amygdala--cingulate circuitry compared with those with the CT/TT genotype. (**a**) Group differences are shown in the horizontal (left), sagittal (middle) and coronal (right) planes between the groups. (**b**) Regions associated with amygdala functional activity at resting state in the CC genotype group. (**c**) Regions associated with amygdala functional activity at resting state in those with the CT/TT genotypes. Orange is indicative of significant positive associations/greater connectivity, and blue is indicative of significant negative associations/lesser connectivity. All signals represent whole-brain corrected voxels at *P*\<0.05.](mp2016250f4){#fig4}

![Tone-shock exposure mediated alterations in *Hdac4* expression are influenced by estrogen status. (**a**) Mouse amygdala *Hdac4* immunohistochemistry (red=*Hdac4*; blue=4,6-diamidino-2-phenylindole/Hoechst). (**b**) Amygdala *Hdac4* mRNA expression in ovariectomized mice in the presence (Est) or absence (Ovx) of estrogen 2 h after tone-shock exposure (FC) compared with homecage (HC) controls. Mean *Hdac4* foldchange relative to HC-Ovx and normalized to *Gapdh* foldchange. (**c**) Amygdala *Hdac4* level in naturally cycling female mice in either metestrous (Met) or proestrous (Pro) 2 h after tone-shock exposure (FC) compared with HC controls. Mean *Hdac4* foldchange relative to HC-Met and normalized to *Gapdh* fold change. BLA, basal lateral nucleus of the amygdala; NS, nonsignificant.](mp2016250f5){#fig5}
